iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

sidebar image

Saveo raises $4.5 million in investment

3 Oct 2022 , 12:48 PM

A venture round co-led by Matrix Partners, Gunosy Capital, and 4Point0 Health Ventures has raised $4.5 million for Saveo, a B2B e-commerce platform for Indian pharmacies. The round also included participation from previous investors LC Nueva, Jetty Ventures, Ocgrow Ventures, Capier Investments, RTP Global, India Quotient, and Incubate Fund.

The B2B startup was valued at $50 million in the most recent round. A seed round of $4 million had been raised by the business in January 2021, and a convertible round of $4.5 million had been raised in January 2022.

By developing new hubs and utilizing cutting-edge technological solutions to construct a full-stack tech platform, Saveo will use the financing to grow into new countries and further penetrate existing geographies.

For feedback and suggestions, write to us at editorial@iifl.com

Related Tags

  • funding
  • Saveo
sidebar mobile

BLOGS AND PERSONAL FINANCE

Read More
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.